One week eradication regimen for Helicobacter pylori.

Area of Science:

• Gastroenterology
• Infectious Diseases
• Pharmacology

Background:

• Helicobacter pylori infection is a common cause of gastritis and duodenal ulcer recurrence.
• Existing treatment regimens for H. pylori eradication lack complete safety and efficacy.

Purpose of the Study:

• To evaluate the efficacy and safety of a short-term eradication regimen for H. pylori infection.
• To assess the impact of metronidazole resistance on treatment outcomes.

Main Methods:

• A seven-day regimen including tripotassium dicitrato bismuthate, amoxycillin, and metronidazole was administered to 106 patients with H. pylori infection.
• Patients had peptic ulceration or non-ulcer dyspepsia.
• H. pylori eradication rates and side-effects were monitored; metronidazole sensitivity was assessed.

Main Results:

• H. pylori was successfully eradicated in 76/106 (72%) patients.
• Eradication rates were significantly higher in patients with metronidazole-sensitive H. pylori (93%) compared to those with resistant strains.
• Mild side-effects were reported, most commonly taste disturbance.

Conclusions:

• A one-week eradication regimen is a safe, effective, and well-tolerated treatment option for H. pylori.
• Metronidazole sensitivity is a key factor in the success of this regimen.
• This treatment offers a cost-effective approach for metronidazole-sensitive H. pylori infections.